Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-small Cell Lung Cancer
Background: The purpose of the present study was to evaluate the efficacy and safety of single-fraction carbon-ion radiotherapy (CIRT) in patients with non-small cell lung cancer. Methods: Patients with histologically confirmed non-small cell lung cancer, stage T1-2N0M0, and treated with single-frac...
Main Authors: | Takashi Ono, Naoyoshi Yamamoto, Akihiro Nomoto, Mio Nakajima, Yuka Isozaki, Goro Kasuya, Hitoshi Ishikawa, Kenji Nemoto, Hiroshi Tsuji |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/112 |
Similar Items
-
The Risk Factors for Radiation Pneumonitis after Single-Fraction Carbon-Ion Radiotherapy for Lung Cancer or Metastasis
by: Takashi Ono, et al.
Published: (2021-06-01) -
A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy
by: Hongshan Ji, et al.
Published: (2022-07-01) -
Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
by: Takashi Ono, et al.
Published: (2022-10-01) -
Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort
by: Marie Bruand, et al.
Published: (2022-12-01) -
Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon—A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence
by: Camil Ciprian Mireștean, et al.
Published: (2022-10-01)